Home / Quetiapine / Canada
CA ATC N05AH04 · updated 2 Nov 2026
Quetiapine shortage in Canada
Is there a Quetiapine shortage in Canada?
Yes. As of 2 Nov 2026, 48 Quetiapine products are reported short in Canada, the first since 1 Apr 2017. The company estimate for the return is 30 Nov 2026 (latest 26 Feb 2027). Main reason: manufacturing problem.
Also short in Germany, France, Italy, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MAR-QUETIAPINE (500 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-QUETIAPINE (500 Tabs) | MARCAN PHARMACEUTICALS INC | 31 Dec 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-QUETIAPINE (100 Tablet) | MARCAN PHARMACEUTICALS INC | 30 Mar 2019 | not given | Other Other (Please describe in comments) |
| CA | MAR-QUETIAPINE (100 Tablet) | MARCAN PHARMACEUTICALS INC | 30 Mar 2019 | not given | Other Other (Please describe in comments) |
| CA | MAR-QUETIAPINE (100 Tablet) | MARCAN PHARMACEUTICALS INC | 30 Mar 2019 | not given | Other Other (Please describe in comments) |
| CA | MAR-QUETIAPINE (100 Tablet) | MARCAN PHARMACEUTICALS INC | 30 Mar 2019 | not given | Other Other (Please describe in comments) |
| CA | MAR-QUETIAPINE (500 TABLET) | MARCAN PHARMACEUTICALS INC | 30 Mar 2019 | not given | Other Other (Please describe in comments) |
| CA | MAR-QUETIAPINE (500 TABLET) | MARCAN PHARMACEUTICALS INC | 30 Mar 2019 | not given | Other Other (Please describe in comments) |
| CA | BIO-QUETIAPINE (100) | BIOMED PHARMA | 31 Mar 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE (100 BTL and 500 BTL) | APOTEX INC | 8 Jun 2021 | not given | Other Other (Please describe in comments) |
| CA | APO-QUETIAPINE (100 BTL and 500 BTL) | APOTEX INC | 8 Jun 2021 | not given | Other Other (Please describe in comments) |
| CA | APO-QUETIAPINE (100 BTL and 500 BTL) | APOTEX INC | 24 Aug 2021 | not given | Other Other (Please describe in comments) |
| CA | APO-QUETIAPINE (100 BTL) | APOTEX INC | 25 Aug 2021 | not given | Other Other (Please describe in comments) |
| CA | APO-QUETIAPINE FUMARATE (100 BTL) | APOTEX INC | 20 Feb 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE XR (60 BTL) | APOTEX INC | 5 Dec 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-QUETIAPINE FUMARATE XR (60) | ACCORD HEALTHCARE INC | 15 Dec 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-QUETIAPINE XR (Bottle 60's) | NORA PHARMA INC | 1 Jan 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-QUETIAPINE XR (Bottle 60's) | NORA PHARMA INC | 1 Jan 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-QUETIAPINE XR (Bottle 60's) | NORA PHARMA INC | 1 Jan 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MINT-QUETIAPINE XR (100 count bottle) | MINT PHARMACEUTICALS INC | 18 Jan 2024 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MINT-QUETIAPINE XR (100 count bottle) | MINT PHARMACEUTICALS INC | 18 Jan 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE TABLETS (100) | ACCORD HEALTHCARE INC | 19 Jan 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | QUETIAPINE XR (100) | JAMP PHARMA CORPORATION | 19 Jan 2024 | 26 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE XR (100) | JAMP PHARMA CORPORATION | 19 Jan 2024 | 26 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE FUMARATE (100 BTL) | APOTEX INC | 20 Feb 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE TABLETS (100) | ACCORD HEALTHCARE INC | 3 Apr 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | QUETIAPINE FUMARATE XR (100) | SANIS HEALTH INC | 13 Apr 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE XR (60 BTL) | APOTEX INC | 28 May 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE XR (60 BTL) | APOTEX INC | 16 Jul 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE FUMARATE XR (100) | SANIS HEALTH INC | 9 Aug 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE FUMARATE XR (100) | SANIS HEALTH INC | 30 Aug 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE FUMARATE (100 BTL) | APOTEX INC | 4 Sep 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE FUMARATE (100 BTL) | APOTEX INC | 4 Sep 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE FUMARATE XR (100) | SANIS HEALTH INC | 4 Oct 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE FUMARATE XR (100) | SANIS HEALTH INC | 8 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE XR (60 BTL) | APOTEX INC | 12 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-QUETIAPINE XR (60 BTL) | APOTEX INC | 12 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-QUETIAPINE FUMARATE XR (60) | ACCORD HEALTHCARE INC | 13 Dec 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | NRA-QUETIAPINE XR (Bottle 60's) | NORA PHARMA INC | 17 Mar 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-QUETIAPINE XR (Bottle 60's) | NORA PHARMA INC | 2 Jun 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE XR (100) | JAMP PHARMA CORPORATION | 7 Aug 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE XR (100) | JAMP PHARMA CORPORATION | 7 Aug 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | QUETIAPINE XR (100) | JAMP PHARMA CORPORATION | 7 Aug 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-QUETIAPINE XR (60) | TEVA CANADA LIMITED | 2 Sep 2025 | 30 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-QUETIAPINE XR (60) | TEVA CANADA LIMITED | 8 Jan 2026 | 30 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-QUETIAPINE (100) | ACCORD HEALTHCARE INC | 10 Jul 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-QUETIAPINE (100) | ACCORD HEALTHCARE INC | 10 Jul 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-QUETIAPINE (100) | ACCORD HEALTHCARE INC | 10 Jul 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.